This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Jichi Medical University, National Institutes of Biomedical Innovation, Health and Nutrition. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 985 
2 out of 33 
2 out of 23 Years Active: 2021-2023
Title: Tadashi Sankai: Innovator in IL-8 Related Therapeutics
Introduction
Tadashi Sankai is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods for IL-8 related diseases. With a total of two patents to his name, Sankai's work stands at the forefront of medical innovation.
Latest Patents
Sankai's latest patents include two closely related innovations: a composition for prophylaxis or treatment of IL-8 related diseases and a method for treating IL-8-related diseases. Both patents focus on the use of an IL-8 signal inhibitor and a novel anti-IL-8 antibody for therapeutic applications. These inventions aim to provide effective therapeutic methods for both known and novel IL-8-related diseases, offering new hope for patients suffering from these conditions.
Career Highlights
Throughout his career, Tadashi Sankai has worked with notable organizations such as Chugai Seiyaku Co., Ltd. and Jichi Medical University. His roles at these institutions have allowed him to engage in innovative research and development, ultimately leading to his impactful patents.
Collaborations
Sankai has collaborated with several colleagues, including Ayako Kakiuchi and Atsuhiko Kato. These partnerships have enhanced his research efforts, contributing to the advancement of knowledge in therapeutic developments for IL-8 related diseases.
Conclusion
Tadashi Sankai's work exemplifies the critical role of inventors in advancing medical science. With his innovative patents aimed at combating IL-8 related diseases, he continues to play a pivotal role in improving patient outcomes and pushing the boundaries of therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile